Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine

Orkhan Isayev(Heidelberg University), Ingrid Herr(Heidelberg University)
Oncotarget
June 15, 2014
Cited by 66


Related Papers